WallStSmart

Becton Dickinson and Company (BDX)vsMerit Medical Systems Inc (MMSI)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Becton Dickinson and Company generates 1341% more annual revenue ($22.23B vs $1.54B). MMSI leads profitability with a 9.0% profit margin vs 5.1%. BDX appears more attractively valued with a PEG of 1.11. BDX earns a higher WallStSmart Score of 65/100 (B-).

BDX

Strong Buy

65

out of 100

Grade: B-

Growth: 6.0Profit: 5.0Value: 6.0Quality: 5.0
Piotroski: 6/9Altman Z: 1.49

MMSI

Buy

61

out of 100

Grade: C+

Growth: 7.3Profit: 6.0Value: 4.7Quality: 7.5
Piotroski: 4/9Altman Z: 2.44
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

BDXUndervalued (+9.9%)

Margin of Safety

+9.9%

Fair Value

$200.45

Current Price

$151.16

$49.29 discount

UndervaluedFair: $200.45Overvalued
MMSISignificantly Overvalued (-49.5%)

Margin of Safety

-49.5%

Fair Value

$54.37

Current Price

$64.48

$10.11 premium

UndervaluedFair: $54.37Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BDX2 strengths · Avg: 8.0/10
Price/BookValuation
1.7x8/10

Reasonable price relative to book value

EPS GrowthGrowth
28.6%8/10

Earnings expanding 28.6% YoY

MMSI2 strengths · Avg: 8.0/10
Price/BookValuation
2.4x8/10

Reasonable price relative to book value

EPS GrowthGrowth
38.8%8/10

Earnings expanding 38.8% YoY

Areas to Watch

BDX4 concerns · Avg: 3.0/10
P/E RatioValuation
25.4x4/10

Moderate valuation

Return on EquityProfitability
4.7%3/10

ROE of 4.7% — below average capital efficiency

Profit MarginProfitability
5.1%3/10

5.1% margin — thin

Altman Z-ScoreHealth
1.492/10

Distress zone — elevated risk

MMSI1 concerns · Avg: 4.0/10
P/E RatioValuation
28.7x4/10

Moderate valuation

Comparative Analysis Report

WallStSmart Research

Bull Case : BDX

The strongest argument for BDX centers on Price/Book, EPS Growth. PEG of 1.11 suggests the stock is reasonably priced for its growth.

Bull Case : MMSI

The strongest argument for MMSI centers on Price/Book, EPS Growth. PEG of 1.41 suggests the stock is reasonably priced for its growth.

Bear Case : BDX

The primary concerns for BDX are P/E Ratio, Return on Equity, Profit Margin.

Bear Case : MMSI

The primary concerns for MMSI are P/E Ratio.

Key Dynamics to Monitor

MMSI carries more volatility with a beta of 0.53 — expect wider price swings.

MMSI is growing revenue faster at 7.5% — sustainability is the question.

BDX generates stronger free cash flow (546M), providing more financial flexibility.

Monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

BDX scores higher overall (65/100 vs 61/100). Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Becton Dickinson and Company

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Becton, Dickinson and Company, also known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies.

Visit Website →

Merit Medical Systems Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, intensive care, and endoscopy. The company is headquartered in South Jordan, Utah.

Want to dig deeper into these stocks?